|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 9/50 | (2006.01) |
| A61K 31/135 | (2006.01) |
| (11) | Number of the document | 2531181 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11707489.8 |
| Date of filing the European patent application | 2011-02-03 | |
| (97) | Date of publication of the European application | 2012-12-12 |
| (45) | Date of publication and mention of the grant of the patent | 2019-04-10 |
| (46) | Date of publication of the claims translation | 2019-07-10 |
| (86) | Number | PCT/IL2011/000126 |
| Date | 2011-02-03 |
| (87) | Number | WO 2011/095973 |
| Date | 2011-08-11 |
| (30) | Number | Date | Country code |
| 301019 P | 2010-02-03 | US |
| (72) |
SELA, Yoram, IL
LIVNAH, Nurit, IL
LAMENSDORF, Itschak, IL
MADMON, Tomer, IL
|
| (73) |
Pharma Two B Ltd.,
3 Pekeris Street Park Tamar, 76702 Rehovot,
IL
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Rasagilino uždelsto atpalaidavimo kompozicijos ir jų panaudojimas |
| EXTENDED RELEASE FORMULATIONS OF RASAGILINE AND USES THEREOF |
| Payment date | Validity (years) | Amount | |
| 2024-01-23 | 14 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2025-02-03 |